BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 22398597)

  • 1. Cystic fibrosis drug Vertex's latest triumph.
    Ledford H
    Nat Biotechnol; 2012 Mar; 30(3):201-2. PubMed ID: 22398597
    [No Abstract]   [Full Text] [Related]  

  • 2. Mutation-specific therapy in cystic fibrosis: the earlier, the better.
    Tümmler B
    Lancet Respir Med; 2013 Oct; 1(8):591-592. PubMed ID: 24461654
    [No Abstract]   [Full Text] [Related]  

  • 3. Excitement mounts for first disease-modifying cystic fibrosis drugs.
    Opar A
    Nat Rev Drug Discov; 2011 Jul; 10(7):479-80. PubMed ID: 21720393
    [No Abstract]   [Full Text] [Related]  

  • 4. Personalized medicine. New cystic fibrosis drug offers hope, at a price.
    Kaiser J
    Science; 2012 Feb; 335(6069):645. PubMed ID: 22323790
    [No Abstract]   [Full Text] [Related]  

  • 5. CT imaging of pediatric patients with cystic fibrosis on ivacaftor therapy.
    Hayes D; Long FR; McCoy KS; Sheikh SI
    Lung; 2014 Oct; 192(5):823-4. PubMed ID: 25099273
    [No Abstract]   [Full Text] [Related]  

  • 6. First cystic fibrosis drug advances towards approval.
    Sheridan C
    Nat Biotechnol; 2011 Jun; 29(6):465-6. PubMed ID: 21654649
    [No Abstract]   [Full Text] [Related]  

  • 7. Cystic fibrosis transmembrane conductance regulator biomarkers in 'real life': can we evaluate individual efficacy of cystic fibrosis transmembrane conductance regulator therapy?
    van Koningsbruggen-Rietschel S; Naehrlich L
    Ther Adv Respir Dis; 2015 Aug; 9(4):198-200. PubMed ID: 26175480
    [No Abstract]   [Full Text] [Related]  

  • 8. Targeting the basic defect in cystic fibrosis.
    Welsh MJ
    N Engl J Med; 2010 Nov; 363(21):2056-7. PubMed ID: 21083391
    [No Abstract]   [Full Text] [Related]  

  • 9. A combination therapy for cystic fibrosis.
    Brodsky JL; Frizzell RA
    Cell; 2015 Sep; 163(1):17. PubMed ID: 26406363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystic fibrosis, ivacaftor, and the Arg117His-CFTR mutation.
    Accurso FJ
    Lancet Respir Med; 2015 Jul; 3(7):498-9. PubMed ID: 26170070
    [No Abstract]   [Full Text] [Related]  

  • 11. Ivacaftor imaging response in cystic fibrosis.
    Hoare S; McEvoy S; McCarthy CJ; Kilcoyne A; Brady D; Gibney B; Gallagher CG; McKone EF; Dodd JD
    Am J Respir Crit Care Med; 2014 Feb; 189(4):484. PubMed ID: 24528318
    [No Abstract]   [Full Text] [Related]  

  • 12. Ivacaftor in a G551D homozygote with cystic fibrosis.
    Harrison MJ; Murphy DM; Plant BJ
    N Engl J Med; 2013 Sep; 369(13):1280-2. PubMed ID: 24066763
    [No Abstract]   [Full Text] [Related]  

  • 13. Ivacaftor.
    Davis PB; Yasothan U; Kirkpatrick P
    Nat Rev Drug Discov; 2012 Apr; 11(5):349-50. PubMed ID: 22543461
    [No Abstract]   [Full Text] [Related]  

  • 14. Cystic fibrosis drug is not cost effective, says NICE.
    Gulland A
    BMJ; 2016 Jun; 353():i3409. PubMed ID: 27325384
    [No Abstract]   [Full Text] [Related]  

  • 15. Potentiators for cystic fibrosis - targeting the underlying molecular defect.
    Patel S; Sinha IP; Dwan K; Echevarria C; Schechter M; Southern KW
    Paediatr Respir Rev; 2015 Jun; 16(3):162-4. PubMed ID: 26002404
    [No Abstract]   [Full Text] [Related]  

  • 16. Mutation-specific cystic fibrosis treatments on verge of approval.
    Dolgin E
    Nat Med; 2011 Apr; 17(4):396-7. PubMed ID: 21475213
    [No Abstract]   [Full Text] [Related]  

  • 17. Intestinal Current Measurements Detect Activation of Mutant CFTR in Patients with Cystic Fibrosis with the G551D Mutation Treated with Ivacaftor.
    Graeber SY; Hug MJ; Sommerburg O; Hirtz S; Hentschel J; Heinzmann A; Dopfer C; Schulz A; Mainz JG; Tümmler B; Mall MA
    Am J Respir Crit Care Med; 2015 Nov; 192(10):1252-5. PubMed ID: 26568242
    [No Abstract]   [Full Text] [Related]  

  • 18. Cystic fibrosis transmembrane regulator potentiators as promising cystic fibrosis therapies.
    Antoniu SA
    Expert Opin Investig Drugs; 2011 Mar; 20(3):423-5. PubMed ID: 21303308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modifying disease in cystic fibrosis: current and future therapies on the horizon.
    Ong T; Ramsey BW
    Curr Opin Pulm Med; 2013 Nov; 19(6):645-51. PubMed ID: 24048086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PharmGKB summary: very important pharmacogene information for CFTR.
    McDonagh EM; Clancy JP; Altman RB; Klein TE
    Pharmacogenet Genomics; 2015 Mar; 25(3):149-56. PubMed ID: 25514096
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.